期刊文献+

2型糖尿病合并阻塞性睡眠呼吸暂停低通气综合征患者夜间血糖波动增加微血管并发症的风险 被引量:3

Nocturnal blood glucose fluctuation of type 2 diabetes mellitus complicated with obstructive sleep apnea hypopnea syndrome increases the risk of microvascular complications
原文传递
导出
摘要 目的探讨2型糖尿病(T2DM)合并阻塞性睡眠呼吸暂停低通气综合征(OSAHS)患者夜间血糖波动与微血管并发症的关系。方法选择2014年6月至12月我院住院诊断为T2DM合并OSAHS患者55例为病例组,其中男性34例,女性21例,平均年龄(61±6)岁,未合并OSAHS的T2DM患者55例为对照组,其中男性30例,女性25例,平均年龄(60±5)岁。检测血糖、血脂、糖化血红蛋白(HbA1c)、24h尿微量白蛋白(UMA)等相关生化指标。采用动态血糖监测系统(CGMS)监测两组患者平均血糖波动幅度(MAGE)、夜间血糖水平的标准差(SDBG)、日间血糖平均绝对差(MODDl以及最大血糖波动幅度(LAGE)、低血糖时间百分比(〈3.9mmol/L)、高血糖时间百分LL(〉7.8mmol/L)、高血糖时间百分比(〉11.1mmol/L)及血糖波动系数,采用多导睡眠图(PSG)监测睡眠呼吸暂停指数(AHI),并检测患者微血管并发症发生情况。采用t检验、χ2检验、方差分析、Pearson积矩相关分析、Logistic多因素分析进行数据统计。结果(1)随着AHI的增加,其MAGE、SDBG、MODD、LAGE、低血糖时间百分比(〈3.9retool/L)及血糖波动系数也随之增加(F=28.137、26.226、19.802、17.734、29.132、29.404,均P〈0.05)。(2)AHI与MAGE、SDBG及血糖波动系数呈正相关(r=0.465、0.696、0.533,均P〈0.05)。(3)病例组的微血管并发症发生率明显高于对照组,差异有统计学意义(81.8%比32.7%,χ2=27.08,P〈0.05)。(4)Logistic分析显示HbA1c(OR=9.646,95%CI:2.381~39.076)、AHI[7.435(1.834~30.134)1、MAGE[10.052(1.057~95.622)]、SDBG[6.435(1.414-29.287)]、LAGE[12.199(2.322~99.613)]、血糖波动系数[8.511(2.012-35.787)1、糖尿病病程[11.769(3.642~43.005)]是T2DM合并微血管并发症的危险因素。结论合并OSAHS可增加T2DM患者血糖波动幅度及频率,T2DM合并OSAHS患者夜间血糖波动与微血管并发症有关。 Objective To investigate the association between blood glucose fluctuation and mierovascular complications in type 2 diabetes mellitus patients complicated with obstructive sleep apnea hypopnea syndrome(OSAHS). Methods 55 patients(34 males and 21 females,with an average of (61 ±6) years old) complicated with OSAHS were enrolled as case group,and 55 patients (30 males and 25 females, with an average of (60±5)years old) without OSAHS were enrolled as control group.Blood glucose, blood lipid, glycosylated hemoglobin A1c (HbA1c),and 24 h urinary microalbumin (24 hUMA) was detected. Dynamic glucose monitoring system(CGMS) was used to monitor the values of mean amplitude of glycemic excursions (MAGE),standard deviation of blood glucose (SDBG), mean of daily differences (MODD),largest amplitude of glycemic excursions (LAGE),the low blood glucose time percentage(〈3.9 mmol/L), high blood glucose time percentage(〉7.8 mmol/L), high blood glucose time percentage(〉ll.1 mmol/L) and blood glucose fluctuation coefficient.Apnea hypopnea index (AHI) was monitored by polysomnography (PSG), microvascular complications of all patients were also detected.t test,χ2 test,variance analysis, Pearson product moment correlation analysis and Logistic multivariate analysis were used to evaluate the data. Results (1)The values of MAGE,SDBG, MODD,LAGE,low blood glucose time percentage(〈3.9 mmol/L) and blood glucose fluctuation coefficient(F=28.137,26.226,19.802,17.734,29.132,29.404,all P〈0.05) were significantly inereased with the inerease of AHI.(2)AHI was positively related with MAGE,SDBG, and blood glucose fluctuation eoeffieient (r=0.465,0.696,0.533,all P〈0.05). (3) The incidence of microvaseular eomplications in case group (81.8%) was signifieantly higher than that in control group (32.7%, χ2=27.08, P〈0.05).(4) Logistie analysis showed that HbA1c,(OR=9.646,95%Ch2.381-39.076), AHI(OR=7.435,95%Chl.834-30.134), MAGE(OR=10.052, 95%Ch1.057-95.622), SDBG(OR=6.435,95%Chl.414-29.287), LAGE(OR=12.199,95% Ch2.322-99.613),blood glueose fluctuation eoeffieient (OR=8.511,95% Ch2.012-35.787), the duration of diabetes (OR=11.769,95% Ch 3.642-43.005) was the risk faetor of T2DM compliaced with mierovaseular eomplication. Conclusions The merger of OSAHS could increase blood glueose fluctuation and frequency in T2DM patients.Noeturnal glueose fluctuation was associated with mierovaseular eomplieations in T2DM patients complicated with OSAHS.
出处 《中华糖尿病杂志》 CAS CSCD 2015年第10期624-628,共5页 CHINESE JOURNAL OF DIABETES MELLITUS
关键词 糖尿病 2型 睡眠呼吸暂停 阻塞性 血糖波动 微血管并发症 Diabetes mellitus, type 2 Sleep apnea, obstructive Blood glucose fluctuation Microvascular complications
  • 相关文献

参考文献2

二级参考文献209

  • 1王雅辉,苏梅,丁宁,张希龙.阻塞性睡眠呼吸暂停低通气综合征与2型糖尿病的相关性研究[J].中华糖尿病杂志,2010,2(3). 被引量:9
  • 2[37]Boulton AJ.Management of diabetic peripheral neuropathy.Clinical Diabetes 2005; 23:9-15
  • 3[38]Belgrade MJ,Cole BE,McCarberg BH,McLean MJ.Diabetic peripheral neuropathic pain:case studies.Mayo Clin Proc 2006;81:S26-S32
  • 4[39]Pfeifer MA,Ross DR,Schrage JP,Gelber DA,Schumer MP,Crain GM,Markwell SJ,Jung S.A highly successful and novel model for treatment of chronic painful diabetic peripheral neuropathy.Diabetes Care 1993; 16:1103-1115
  • 5[40]Benbow SJ,MacFarlane IA.Painful diabetic neuropathy.Baillieres Best Pract Res Clin Endocrinol Metab 1999; 13:295-308
  • 6[41]Dyck PJ,Giannini C.Pathologic alterations in the diabetic neuropathies of humans:a review.J Neuropathol and Exp Neurol 1996; 55:1181-1193
  • 7[42]Thomas PK.Diabetic neuropathy:mechanisms and future treatment options.J Neurol Neurosurg Psychiatry 1999; 67:277-279
  • 8[43]Zochodne DW.Neurotrophins and other growth factors in diabetic neuropathy.Semin Neurol 1996; 16:153-161
  • 9[44]Liuzzi FJ,Bufton SM,Vinik Al.Streptozotocin-induced diabetes mellitus causes changes in primary sensory neuronal cytoskeletal mRNA levels that mimic those caused by axotomy.Exp Neurol 1998; 154:381-388
  • 10[45]Koltzenburg M,Scadding J.Neuropathic pain.Curr Opin Neurol 2001; 14:641-647

共引文献59

同被引文献30

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部